If you need any help or a chat then IM/PM or email me, Chip

Author Topic: Chantix (Varenicline) an Anti-smoking Medication Reduces Alcohol Dependence  (Read 183 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6279
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:Today at 07:45:44 AM
  • Deeply Confused Learner
  • Profession: IT Engineer
source: https://www.nih.gov/news-events/nih-research-matters/anti-smoking-medication-reduces-alcohol-dependence

Anti-smoking Medication Reduces Alcohol Dependence

June 17, 2013

A smoking-cessation medication can also help lower alcohol craving and dependence. The finding may lead to another treatment option for alcohol problems.

Alcohol dependence, or alcoholism, is a chronic disease. Signs include craving for alcohol, loss of control over drinking, withdrawal symptoms and tolerance (the need to drink greater amounts to feel the same effect). Alcohol dependence takes a serious toll on a person’s health and quality of life. People who are alcoholic may spend a great deal of time drinking, making sure they can get alcohol and recovering from its effects.

Treatment for alcoholism was once essentially limited to the mutual support group Alcoholics Anonymous. Now, therapies include medications and behavioral approaches, as well as combinations of treatments. Researchers have been exploring a variety of alternative strategies that can help people change their drinking habits.

Varenicline, marketed as Chantix, was approved in 2006 by the U.S. Food and Drug Administration to help people stop smoking. It works by partially stimulating receptors for nicotinic acetylcholine on certain nerve cells. These receptors have been implicated in both nicotine and alcohol disorders. In early studies of varenicline for smoking cessation, participants reported a reduced craving for alcohol and lower alcohol consumption. Experiments found that the drug decreased alcohol consumption in rodents.

To further investigate, a research team led by Dr. Raye Z. Litten of NIH’s National Institute on Alcohol Abuse and Alcoholism (NIAAA) randomized 200 alcohol-dependent adults to receive varenicline or an inactive placebo each day for 13 weeks. Female participants reported an average of at least 28 drinks per week prior to the study, with at least 4 drinks on most days. Males had at least 35 drinks per week and 5 on most days.

As reported online on May 30, 2013, in the Journal of Addiction Medicine, varenicline significantly reduced measures of alcohol use compared with placebo. For example, the percentage of heavy drinking days per week decreased nearly 22% in the varenicline group. Craving for alcohol was also significantly reduced in people treated with varenicline. The effects on alcohol use were similar for smokers and nonsmokers.

Varenicline’s effectiveness was comparable to medications already approved by the FDA for treating alcohol dependence. The drug was also well-tolerated. Mild side effects included nausea, abnormal dreams and constipation.

“Drinking and smoking often co-occur, and given their genetic and neurochemical similarities, it is perhaps unsurprising that a smoking cessation treatment might serve to treat alcohol problems,” Litten says.

“This is an encouraging development in our effort to expand and improve treatment options for people with alcohol dependence,” says NIAAA Acting Director Dr. Kenneth R. Warren. “Current medications for alcohol dependence are effective for some, but not all, patients.”

Longer treatment and follow-up assessments will be needed to determine if varenicline can be an effective long-term treatment for alcohol dependence.
I do not condone or support any illegal activities. All information is for theoretical discussion and wonder.
All activities discussed are considered fictional and hypothetical. Information of all discussion has been derived from online research and in the spirit of personal Freedom.

Tags:
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
1892 Views
Last post July 11, 2015, 02:37:48 AM
by Chip
0 Replies
1999 Views
Last post August 04, 2015, 12:59:14 PM
by Chip
17 Replies
7060 Views
Last post April 15, 2016, 01:01:27 PM
by Taytoechip
15 Replies
6187 Views
Last post November 13, 2016, 08:10:46 PM
by makita
8 Replies
3706 Views
Last post April 18, 2016, 09:26:54 PM
by DreamerOnTheRun
16 Replies
10396 Views
Last post July 26, 2016, 06:01:02 PM
by Chip
6 Replies
3118 Views
Last post July 20, 2017, 10:05:37 PM
by meal5
0 Replies
325 Views
Last post June 01, 2019, 06:29:15 AM
by Chip
0 Replies
542 Views
Last post July 06, 2019, 06:56:48 AM
by Chip
0 Replies
467 Views
Last post August 27, 2019, 09:21:50 PM
by Chip





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE



Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal